#2 – Spiro Rombotis, CEO at Cyclacel Pharmaceuticals

#2 - Spiro Rombotis, CEO at Cyclacel Pharmaceuticals

Share This Post

Episode Details:

Our Guest: Spiro Rombotis, CEO at Cyclacel Pharmaceuticals

What you’ll get out of this episode:

  • Rombotis’s background and an overview of Cyclacel
  • Which part of the cell cycle they’re targeting?
  • What their leading candidates are, and the current clinical trial statuses of each.
  • What makes their CDK inhibitor strategy unique compared to other biopharmaceutical companies?
  • Their PLK1 program
  • Near-term milestones and what’s next?

Watch

Listen


WORD FROM OUR SPONSORS:

Our sponsor for this episode are Sage Growth Partners.

Sage Growth Partners accelerates commercial success for healthcare organizations through a singular focus on growth. The company helps its clients thrive amid the complexities of a rapidly changing marketplace with deep domain expertise and an integrated application of research, strategy, and marketing. For more information, please go to www.sage-growth.com & follow Sage Growth Partners on social media – @sagegrowthpartners


Learn more about Cyclacel Pharmaceuticals follow these links:

LinkedInWebsite


Also, be sure to follow Slice of Healthcare on our social channels:

– Website  – LinkedIn – Twitter – YouTube – Newsletter

More To Explore

Total
0
Share